Subscribe
istock-693373540_natali_mis
Natali_Mis / iStockphoto.com
7 March 2018Europe

EPO grants second CRISPR patent to ERS Genomics

The European Patent Office (EPO) has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
USPTO grants Charpentier-founded company first CRISPR patent
20 June 2018   The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.
Biotechnology
ERS Genomics signs CRISPR patent deal on industrial applications
16 October 2018   ERS Genomics, the company providing access to CRISPR/Cas9 IP owned by Emmanuelle Charpentier, has signed a licensing deal with synthetic biology startup Syngulon.
Americas
USPTO grants another CRISPR patent to Charpentier
12 March 2019   The US Patent and Trademark Office has issued a third CRISPR patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
USPTO grants Charpentier-founded company first CRISPR patent
20 June 2018   The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.
Biotechnology
ERS Genomics signs CRISPR patent deal on industrial applications
16 October 2018   ERS Genomics, the company providing access to CRISPR/Cas9 IP owned by Emmanuelle Charpentier, has signed a licensing deal with synthetic biology startup Syngulon.
Americas
USPTO grants another CRISPR patent to Charpentier
12 March 2019   The US Patent and Trademark Office has issued a third CRISPR patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

More on this story

Americas
USPTO grants Charpentier-founded company first CRISPR patent
20 June 2018   The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing.
Biotechnology
ERS Genomics signs CRISPR patent deal on industrial applications
16 October 2018   ERS Genomics, the company providing access to CRISPR/Cas9 IP owned by Emmanuelle Charpentier, has signed a licensing deal with synthetic biology startup Syngulon.
Americas
USPTO grants another CRISPR patent to Charpentier
12 March 2019   The US Patent and Trademark Office has issued a third CRISPR patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility